Stay updated on VenDex vs PomDex in t(11;14)+ MM Clinical Trial
Sign up to get notified when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.

Latest updates to the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page
- ChecktodayChange DetectedPublications section updated with a PubMed citation for the CANOVA primary results (J Clin Oncol, 2025). The update does not modify study design, eligibility, or endpoints.SummaryDifference0.2%

- Check7 days agoChange DetectedThe page no longer displays the topic 'Multiple Myeloma' and the related 'MedlinePlus Genetics' link. This reduces disease context and access to related resources for users.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.1 on the page. No changes to study details, eligibility criteria, or locations are evident.SummaryDifference0.6%

- Check30 days agoChange DetectedThe government funding status notice was removed from the page. The study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.1%

- Check45 days agoChange DetectedNo meaningful updates to the Study Details page were observed. The core content and sections appear unchanged.SummaryDifference0.2%

Stay in the know with updates to VenDex vs PomDex in t(11;14)+ MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.